Da-zhuo, S., Jian-gang, L. & Guo-ju, D. Therapeutic mechanism of Yuxingeng liquid on early ventricular remodeling with acute myocardial infarction in rats., Chin. J. Integr. Med. 9, 215–218 (2003). https://doi.org/10.1007/BF02838038
Shi Da-zhuo, Liu Jian-gang, Dong Guo-ju. Therapeutic mechanism of Yuxingeng liquid on early ventricular remodeling with acute myocardial infarction in rats. [J]. Chinese Journal of Integrative Medicine 9(3):215-218(2003)
Da-zhuo, S., Jian-gang, L. & Guo-ju, D. Therapeutic mechanism of Yuxingeng liquid on early ventricular remodeling with acute myocardial infarction in rats., Chin. J. Integr. Med. 9, 215–218 (2003). https://doi.org/10.1007/BF02838038DOI:
Shi Da-zhuo, Liu Jian-gang, Dong Guo-ju. Therapeutic mechanism of Yuxingeng liquid on early ventricular remodeling with acute myocardial infarction in rats. [J]. Chinese Journal of Integrative Medicine 9(3):215-218(2003) DOI: 10.1007/BF02838038.
Therapeutic mechanism of Yuxingeng liquid on early ventricular remodeling with acute myocardial infarction in rats
摘要
Objective: To examine the therapeutic mechanism of Yuxingeng liquid (YXGL) on early ventricular remodeling in Wistar rats with acute myocardial infarction(AMI).Methods: Measuring the cardiac index (CI)
left ventricular weight (LVW) and cardiac myocyte dimension and observing the concentration of endothelin (ET) and angiotensin II (Ang II) in the plasma and myocardium. AMI models were established by ligature of left anterior descending coronary artery and the rats with AMI were randomly divided into 6 groups: the model group
sham-operation group
captopril group
high dosage YXGL group
middle dosage YXGL group and low dosage YXGL group. From the next day after modeling
the rats had been given YXGL through the gastric tube
which lasted for 4 weeks. And then
CI
LVW and concentration of ET and Ang II in the plasma and myocardium were tested.Results: Comparing with model control group
high dosage YXGL
middle dosage YXGL and captopril can all significantly reduce CI
LVW
cardiac cell dimension and content of ET and Ang II in both plasma and myocardium (P < 0.05 orP < 0.01).Conclusion: YXGL can remarkably reduce LVW
CI and concentration of ET and Ang II
and lowering the concentration of ET and Ang II is possibly one of the mechanisms intervening the pathological course of the early ventricular remodeling in rats with AMI.
Abstract
Objective: To examine the therapeutic mechanism of Yuxingeng liquid (YXGL) on early ventricular remodeling in Wistar rats with acute myocardial infarction(AMI).Methods: Measuring the cardiac index (CI)
left ventricular weight (LVW) and cardiac myocyte dimension and observing the concentration of endothelin (ET) and angiotensin II (Ang II) in the plasma and myocardium. AMI models were established by ligature of left anterior descending coronary artery and the rats with AMI were randomly divided into 6 groups: the model group
sham-operation group
captopril group
high dosage YXGL group
middle dosage YXGL group and low dosage YXGL group. From the next day after modeling
the rats had been given YXGL through the gastric tube
which lasted for 4 weeks. And then
CI
LVW and concentration of ET and Ang II in the plasma and myocardium were tested.Results: Comparing with model control group
high dosage YXGL
middle dosage YXGL and captopril can all significantly reduce CI
LVW
cardiac cell dimension and content of ET and Ang II in both plasma and myocardium (P < 0.05 orP < 0.01).Conclusion: YXGL can remarkably reduce LVW
CI and concentration of ET and Ang II
and lowering the concentration of ET and Ang II is possibly one of the mechanisms intervening the pathological course of the early ventricular remodeling in rats with AMI.
Schelling P, Stephen B, Harrap P, et al. Angiotension and cell growth: a link to cardiovascular hypertrophy. J Hypertens 1991; 9(6): 3–6.
Villarreal FJ, Kim NN, Ungab GD, et al. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993; 88: 2849–2861.
Sadoshima J, Isuma S. Molecular characterization of angiotensin II induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ Res 1993;73: 413 -423.
Clinical efficacy of traditional chinese medicine on acute myocardial infarction—A prospective cohort study
Effects of Tongguan Capsule (通冠胶囊) on post-myocardial infarction ventricular remodeling and cardiac function in rats
Combined therapy with Chinese medicine and percutaneous transradial coronary intervention for a centenarian patient with acute myocardial infarction
Effect of Chinese drugs for supplementing qi, Nourishing Yin and activating blood circulation on myocardial perfusion in patients with acute myocardial infarction after revascularization
Shi Da-zhuo (史大卓) —An outstanding cardiologist of integrative medicine
Related Author
No data
Related Institution
Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences
Division of Emergency, the Second Clinical College of Guangzhou University of Traditional Chinese Medicine
Heart Center, Guangdong Provincial Hospital of Chinese Medicine
Department of Internal Cardiac Medicine, Tongren Hospital Affiliated to the Capital Medical University
Department of Internal Cardiac Medicine, the People’s Hospital of Peking University